title: Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.
abstract: BACKGROUND
  Although pregnancy-related factors such as nulliparity and late age at first full-term pregnancy are well-established risk factors for invasive breast cancer, the roles of these factors in the natural history of breast cancer development remain unclear.
  
  
  METHODS
  Among 52,464 postmenopausal women participating in the California Teachers Study (CTS), 624 were diagnosed with breast carcinoma in situ (CIS) and 2,828 with invasive breast cancer between 1995 and 2007. Multivariable Cox proportional hazards regression methods were used to estimate relative risks associated with parity, age at first full-term pregnancy, breastfeeding, nausea or vomiting during pregnancy, and preeclampsia.
  
  
  RESULTS
  Compared with never-pregnant women, an increasing number of full-term pregnancies was associated with greater risk reduction for both breast CIS and invasive breast cancer (both P trend < 0.01). Women having four or more full-term pregnancies had a 31% lower breast CIS risk (RR = 0.69, 95% CI = 0.51 to 0.93) and 18% lower invasive breast cancer risk (RR = 0.82, 95% CI = 0.72 to 0.94). Parous women whose first full-term pregnancy occurred at age 35 years or later had a 118% greater risk for breast CIS (RR = 2.18, 95% CI = 1.36 to 3.49) and 27% greater risk for invasive breast cancer (RR = 1.27, 95% CI = 0.99 to 1.65) than those whose first full-term pregnancy occurred before age 21 years. Furthermore, parity was negatively associated with the risk of estrogen receptor-positive (ER+) or ER+/progesterone receptor-positive (PR+) while age at first full-term pregnancy was positively associated with the risk of ER+ or ER+/PR+ invasive breast cancer. Neither of these factors was statistically significantly associated with the risk of ER-negative (ER-) or ER-/PR- invasive breast cancer, tests for heterogeneity between subtypes did not reach statistical significance. No clear associations were detected for other pregnancy-related factors.
  
  
  CONCLUSIONS
  These results provide some epidemiologic evidence that parity and age at first full-term pregnancy are involved in the development of breast cancer among postmenopausal women. The role of these factors in risk of in situ versus invasive, and hormone receptor-positive versus -negative breast cancer merits further exploration.
authors.affiliation: Department of Population Sciences, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA. hma@coh.org
authors.forename: Huiyan
authors.initials: H
authors.lastname: Ma
authors.forename: Katherine D
authors.initials: KD
authors.lastname: Henderson
authors.forename: Jane
authors.initials: J
authors.lastname: Sullivan-Halley
authors.forename: Lei
authors.initials: L
authors.lastname: Duan
authors.forename: Sarah F
authors.initials: SF
authors.lastname: Marshall
authors.forename: Giske
authors.initials: G
authors.lastname: Ursin
authors.forename: Pamela L
authors.initials: PL
authors.lastname: Horn-Ross
authors.forename: Joan
authors.initials: J
authors.lastname: Largent
authors.forename: Dennis M
authors.initials: DM
authors.lastname: Deapen
authors.forename: James V
authors.initials: JV
authors.lastname: Lacey
authors.forename: Leslie
authors.initials: L
authors.lastname: Bernstein
mesh_terms: D000328:Adult; D001942:Breast Feeding; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000378:metabolism; D002140:California / Q000453:epidemiology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000453:epidemiology* / Q000378:metabolism; D005260:Female; D006801:Humans; D015994:Incidence; D009361:Neoplasm Invasiveness; D010298:Parity; D017698:Postmenopause; D011247:Pregnancy; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D018570:Risk Assessment; D012307:Risk Factors; D055815:Young Adult
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone